MDP Stock

Research Capital analyst Andre Uddin maintained a “Buy” rating and C$5.55 price target on Medexu... Read More

Following a key product update, Raymond James analyst Michael W. Freeman remains bullish on Medexus ... Read More

An FDA approval could send one Canadian-listed stock flying, says Raymond James analysts Michael W. ... Read More

With its second quarter results in the books, Raymond James analyst Michael W. Freeman has raised it... Read More

A new development has been a drag on its share price, but Ventum Capital Markets analyst Stefan Quen... Read More

Its Q4 results are in the books and Raymond James analyst Rahul Sarugaser still thinks there is a li... Read More

Following a new development, Echelon Capital Markets analyst Stefan Quenneville has raised his price... Read More

A new development at Medexus Pharmaceuticals (Medexus Pharmaceuticals Stock Quote, Chart, News, Anal... Read More

After a disappointing quarter, Echelon Capital Markets analyst Stefan Quenneville has lowered his pr... Read More

Following moves by the company to shore up its balance sheet, Research Capital analyst Andre Uddin i... Read More

Following a finance move from the company, Raymond James analyst Rahul Sarugaser believes there is a... Read More

It’s been a wild ride for Medexus Pharmaceuticals (Medexus Pharmaceuticals Stock Quote, Charts, Ne... Read More

Echelon Capital Markets analyst Stefan Quenneville stayed bullish on Medexus Pharmaceuticals (Medexu... Read More

After reviewing the latest quarterly results from Medexus Pharmaceuticals (Medexus Pharmaceuticals S... Read More

Strong quarterly revenue looks good on Medexus Pharmaceuticals (Medexus Pharmaceuticals Stock Quote,... Read More

Calling it a compelling opportunity for investors, Echelon Capital Markets analyst Stefan Quennevill... Read More

There’s a favourable risk-reward opportunity to Canadian specialty pharma name Medexus Pharmaceuti... Read More

Biotech, more than any other sector, is a game of longshots. Most great investors in the space own a... Read More